Tardive Dystonia

Prevatence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients
  • Michele Raja
Original Paper


In a population of 200 consecutive inpatients with a history of at least 3 months' total cumulative neuroleptic exposure, the prevalence of tardive dystonia (TDt) was 4%, higher than previously reported. The prevalence of tardive dyskinesia (TDk) was 22%. Patients with TDt did not differ in demographic or clinical variables from nondyskinetic patients. In comparison with patients with TDk, patients with TDt were significantly younger, had a more severe movement disorder, and had received neuroleptics for the first time fewer years before. Patients with TDk were significantly older than patients without tardive disorders, both when they were examined and when they had started their first neuroleptic treatment. Furthermore, they had started their first neuroleptic treatment more years before. These results support the distinction between TDt and TDk, and suggest that the previously reported prevalence of TDt might have been underestimated.

Key words

Prevalence Risk factors Tardive dyskinesia Tardive dystonia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams RD, Victor M (1993) Principles of neurology, 5th edn. McGraw-Hill, New York, pp 71–72Google Scholar
  2. 2.
    Adityanjee, Jayaswal SK, Chan TM, Subramaniam M (1990) ECT for tardive dystonia. Br J Psychiatry 156:433–435Google Scholar
  3. 3.
    Altamura AC, Cavallaro R, Regazzetti MG (1990) Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics. Eur Arch Psychiatry Clin Neurosci 240:9–12Google Scholar
  4. 4.
    American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R) 3rd edn, revised. American Psychiatric Press, Washington, DCGoogle Scholar
  5. 5.
    Angermeyer MC, Kuhn L, Goldstein JM (1990) Gender and the course of schizophrenia: differences in treated outcome. Schizophr Bull 16:293–307Google Scholar
  6. 6.
    Baldessarini RJ (1985) Chemotherapy in psychiatry: principles and practice. Harvard University Press, Cambridge, MassGoogle Scholar
  7. 7.
    Bech P, Kastrup M, Rafaelsen OJ (1986) Minicompendium of rating scales. Acta Psychiatr Scand 73 (Suppl 326)Google Scholar
  8. 8.
    Brown KW, White T (1991) The psychological consequences of tardive dyskinesia. Br J Psychiatry 159:399–403Google Scholar
  9. 9.
    Burke RE, Fahn S, Jankovic J et al. (1987) Tardive dystonia: late onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335–1346Google Scholar
  10. 10.
    Burke RE, Kang UJ (1988) Tardive dystonia: clinical aspects and treatment. In: Fahn S et al (eds) Advances in neurology. Raven Press, New York, 49:199–210Google Scholar
  11. 11.
    Cavallaro R, Regazzetti MG, Mundo E, Brancato V, Smeraldi E (1993) Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence. Neuropsychopharmacology 8:233–239Google Scholar
  12. 12.
    Casey DE (1987) Tardive dyskinesia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New YorkGoogle Scholar
  13. 13.
    Chiu H, Shum P, Lau J, Lam L, Lee S (1992) Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. Am J Psychiatry 149:1081–1085Google Scholar
  14. 14.
    Chouinard G, Annable L, Mercier P, Ross-Chouinard A (1986) A five-year follow-up study of tardive dyskinesia. Psychopharmacol Bull 22:259–263Google Scholar
  15. 15.
    Davis EJB, Borde M, Sharma LN (1992) Tardive dyskinesia and type II schizophrenia. Br J Psychiatry 160:253–256Google Scholar
  16. 16.
    Fahn S (1987) Drug treatment of hyperkinetic movement disorders. Semin Neurol 7:192–208Google Scholar
  17. 17.
    Famuyiwa OO, Eccleston D, Donaldson AA, Garside RF (1979) Tardive dyskinesia and dementia. Br J Psychiatry 135:500–504Google Scholar
  18. 18.
    Flor-Henry P (1990) Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophr Bull 16:211–227Google Scholar
  19. 19.
    Friedman JH, Kuraski LT, Wagner RI (1987) Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 50:801–803Google Scholar
  20. 20.
    Ganzini L, Heintz RT, Hoffman WF, Casey DE (1991) The preyalence of tardive dyskinesia in neuroleptic-treated diabetics. Arch Gen Psychiatry 48:259–263Google Scholar
  21. 21.
    Gelenberg AJ (1987) Treating extrapyramidal reactions: some current issues. J Clin Psychiatry (Suppl 9):24–27Google Scholar
  22. 22.
    Gerlach J, Casey DE (1988) Tardive dyskinesia. Acta Psychiatr Scand 77:369–378Google Scholar
  23. 23.
    Gershanik OS (1993) Drug-induced movement disorders. Curr Opin Neurol Neurosurg 6:369–376Google Scholar
  24. 24.
    Gimenez-Roldan S, Mateo D, Bartolome P (1985) Tardive dystonia and severe tardive dyskinesia. Acta Psychiatr Scand 71:488–494Google Scholar
  25. 25.
    Goldman MB, Luchins DJ (1984) Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Hosp Comm Psychiatry 35:1215–1219Google Scholar
  26. 26.
    Granacher RP (1981) Differential diagnosis of tardive dyskinesia: an overview. Am J Psychiatry 138:1288–1297Google Scholar
  27. 27.
    Harris MJ, Jeste DV (1988) Late-onset schizophrenia: an overview. Schizophr Bull 14:39–55Google Scholar
  28. 28.
    Jeste DV, Wyatt RJ (1982) Understanding and treating dyskinesia. The Guildford Press, New YorkGoogle Scholar
  29. 29.
    Kane JM (1987) Treatment of schizophrenia. Schizophr Bull 13:133–156Google Scholar
  30. 30.
    Kane JM, Struve FA, Weinhold P (1980) Strategy for the study of patients at high risk for tardive dyskinesia. Am J Psychiatry 137:1265–1267Google Scholar
  31. 31.
    Kane JM, Woener M, Lieberman J (1985) Tardive dyskinesia: prevalence, incidence and risk factors. In: Casey DE, Chase T, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology (Suppl 2). Springer, Berlin Heidelberg New York, pp 72–78Google Scholar
  32. 32.
    Kane JM, Woerner M, Borenstein M, Wegner J, Lieberman J (1986) Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 22:254–258Google Scholar
  33. 33.
    Kang UJ, Burke RE, Fahn S (1986) Natural history and treatment of tardive dystonia. Mov Disord 1:193–208Google Scholar
  34. 34.
    Kaplan Z, Benjamin J, Zohar J (1991) Remission of tardive dystonia with ECT. Convulsive Ther 7:280–283Google Scholar
  35. 35.
    Keegan DL, Rajput AH (1973) Drug-induced dystonia tarda: treatment with L-dopa. Dis Nerv Syst 38:167–169Google Scholar
  36. 36.
    Kissling W (1992) Ideal and reality of neuroleptic relapse prevention. Br J Psychiatry 161 (Suppl 18):133–139Google Scholar
  37. 37.
    Korczyn AD, Inzelberg R (1993) Dystonia. Curr Opin Neurol Neurosurg 6:350–357Google Scholar
  38. 38.
    Kraepelin EL (1919) Textbook of Psychiatry, vol 3: dementia praecox. McMillan, LondonGoogle Scholar
  39. 39.
    Lamberti JS, Bellnier T (1993) Clozapine and tardive dystonia. J Nerv Ment Dis 181:137–138Google Scholar
  40. 40.
    Lewine RRJ (1981) Sex differences in schizophrenia: timing or subtypes. Psychol Bull 90:432–444Google Scholar
  41. 41.
    Lewine RRJ, Burbach D, Meltzer HY (1984) The effect of diagnostic criteria on the proportion of male to female schizophrenics. Am J Psychiatry 141:84–87Google Scholar
  42. 42.
    Lieberman JA, Alvir J, Mukherjee S, Kane JM (1989) Treatment of tardive dyskinesia with bromocriptine. Arch Gen Psychiatry 46:908–913Google Scholar
  43. 43.
    Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158:503–510Google Scholar
  44. 44.
    Luchins D, Goldman M (1985) High dose bromocriptine in a case of tardive dystonia. Biol Psychiatry 20:179–181Google Scholar
  45. 45.
    Marsden CD, Quinn NP (1990) The dystonias. Br Med J 300:139–144Google Scholar
  46. 46.
    McClelland HA, Metcalfe AV, Kerr TA et al (1991) Facial dyskinesia: a 16-year follow-up study. Br J Psychiatry 158:691–696Google Scholar
  47. 47.
    Muscettola G, Pampallona S, Barbato G et al (1989) Tardive dyskinesia in Italy: preliminary findings. Arch Gen Psychiatry 46:754–755Google Scholar
  48. 48.
    NIHM, Psychopharmacology Research Branch (1986) Psychopharmacol Bull 24:781–782Google Scholar
  49. 49.
    Overall JE, Gorhan DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812Google Scholar
  50. 50.
    Owens DGC (1990) Dystonia—a potential psychiatric pitfall. Br J Psychiatry 156:620–634Google Scholar
  51. 51.
    Ozelius LJ, Kramer PL, De Leon D, Rish N, Bressman SB, Schuback DE, Brin ME, Kwiatkowski DJ, Burke RE, Gusella JF, Fahn S, Breakfield XO (1992) Strong allelic association between the Torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazi Jews. Am J Human Genet 50:619–628Google Scholar
  52. 52.
    Raja M, Altavista MC, Maisto G (1994) Severe tardive lingual dystonia. In: Focus on dystonia. A Satellite Meeting of the 11th Parkinson's Disease Symposium, Rome, March 25, 1994. Abstract book P04, p 34Google Scholar
  53. 53.
    Roller WC (1988) Tardive dystonia: diagnosis and treatment. In: Wolf ME, Mosnaim AD (eds) Tardive dyskinesia: biological mechanisms and clinical aspects. American Psychiatric Press, Washington, DCGoogle Scholar
  54. 54.
    Rush M, Diamond F, Alpert M (1982) Depression as a risk factor in tardive dyskinesia. Biol Psychiatry 17:387–392Google Scholar
  55. 55.
    Sachdev P (1991) The prevalence of tardive dystonia in patients with chronic schizophrenia (letter). Aust N Z J Psychiatry 25:446–448Google Scholar
  56. 56.
    Sachdev P (1993) Risk factors for tardive dystonia: a case-control comparison with tardive dyskinesia. Acta Psychiatr Scand 88:98–103Google Scholar
  57. 57.
    Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486–487Google Scholar
  58. 58.
    Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA (1990) Clonazepam treatment of tardive dyskinesia: a practical GABA mimetic strategy. Am J Psychiatry 147:445–451Google Scholar
  59. 59.
    Waddington JL, Youssef HA (1986) An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. Am J Psychiatry 143:1162–1165Google Scholar
  60. 60.
    Waddington JL, Youssef HA, Dolphim C, Kinsella A (1987) Cognitive dysfunction negative symptoms, and tardive dyskinesia in schizophrenia. Arch Gen Psychiatry 44:907–912Google Scholar
  61. 61.
    Waddington JL, Youssef HA (1988) The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree. Br J Psychiatry 153:376–381Google Scholar
  62. 62.
    Wahl OF, Hunter J (1992) Are gender effects being neglected in schizophrenia research? Schizophr Bull 18:313–317Google Scholar
  63. 63.
    Westermeyer JF, Harrow M (1984) Prognosis and outcome using broad (DSM-II) and narrow (DSM-III) concepts of schizophrenia. Schizophr Bull 10:624:637Google Scholar
  64. 64.
    Wojcik JD, Falk WE, Fink JS et al (1991) A review of 32 cases of tardive dystonia. Am J Psychiatry 148:1055–1059Google Scholar
  65. 65.
    Wolf ME, Mosnaim AD (1984) Identifying subtypes of tardive dyskinesia. Hosp Community Psychiatry 35:828–830Google Scholar
  66. 66.
    Yassa R, Nair V, Schwartz G (1984) Tardive dyskinesia: a two-year follow-up study. Psychosomatics 25:852–855Google Scholar
  67. 67.
    Yassa R, Nair V, Dimitry R (1986) Prevalence of tardive dystonia. Acta Psychiatry Scand 73:629–633Google Scholar
  68. 68.
    Yassa R, Nair V, Schwartz G (1986) Early versus late onset psychosis and tardive dyskinesia. Biol Psychiatry 21:1291–1297Google Scholar
  69. 69.
    Yassa R, Nair V, Iskandar H (1989) A comparison of severe tardive dystonia and severe tardive dyskinesia. Acta Psychiatr Scand 80:155–159Google Scholar
  70. 70.
    Yassa R, Nair NPV, Iskandar H, Schwartz G (1990) Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry 147:1156–1163Google Scholar
  71. 71.
    Yassa W, Jeste DV (1992) Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701–715Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Michele Raja
    • 1
  1. 1.Servizio psichiatrico di diagnosi e cura, Ospedale “Santo Spirito”Dipartimento di salute mentale USL RM ERomeItaly

Personalised recommendations